Fig 6. DDR in IFN-γ-treated HAP1.
Western blot analysis of the indicated proteins in control or SLFN11 KD HAP1 cells following exposure to 10 ng/ml of IFN-γ for the indicated time periods.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.